Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism

Simple item page
dc.contributor.authorSterrett, J. R.en
dc.contributor.authorStrom, J.en
dc.contributor.authorStummvoll, H-K.en
dc.contributor.authorBahner, Udoen
dc.contributor.authorDisney, Alexander Patrick Suffeen
dc.contributor.authorSoroka, S. D.en
dc.contributor.authorCorpier, C.en
dc.contributor.authorArruda, J. A.en
dc.contributor.authorSchwanauer, L. E.en
dc.contributor.authorKlassen, P. S.en
dc.contributor.authorOlson, K. A.en
dc.contributor.authorBlock, G. A.en
dc.contributor.schoolSchool of Medicine : Medicineen
dc.date.issued2007en
dc.description.statementofresponsibilityJ.R. Sterrett, J. Strom, H.-K. Stummvoll, U. Bahner, A. Disney, S.D. Soroka, C. Corpier, J.A. Arruda, L.E. Schwanauer, P.S. Klassen, K.A. Olson and G.A. Blocken
dc.identifier.citationClinical Nephrology, 2007; 68 (1):10-17en
dc.identifier.issn0301-0430en
dc.identifier.urihttp://hdl.handle.net/2440/44205
dc.language.isoenen
dc.publisherDustri-Verlag Dr Karl Feistleen
dc.source.urihttp://www.clinnephrol.com/index.php?id=10&issueId=222en
dc.titleCinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidismen
dc.typeJournal articleen

Files

Collections

Medicine publications